Apixaban Dose Reduction in Patients With Elevated Drug Levels

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Atrial Fibrillation
Interventions
DRUG

apixaban dose reduction

Participants taking apixaban 5mg BID will have their dose reduced to 2.5mg BID, and those taking 2.5mg BID will have their dose reduced to 2.5mg once daily (in the morning).

Trial Locations (1)

L8L 2X2

Hamilton General Hospital, Hamilton

Sponsors
All Listed Sponsors
collaborator

Population Health Research Institute

OTHER

lead

Hamilton Health Sciences Corporation

OTHER